Is gabapentin effective and safe in the treatment of chronic pelvic pain in women: A systematic review and meta-analysis

Yuewen He, Xuhui Zhuang, Wuhua Ma
In: Authorea, Inc. · 2024 · doi:10.22541/au.170667726.61102973/v1 · W4391395817
Systematic review / meta-analysis OA: gold CC0
📄 Open PDF View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This meta-analysis found gabapentin reduced average pain scores in women with chronic pelvic pain at 3 and 6 months, but also significantly increased side effects compared to placebo.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Background: Chronic pelvic pain (CPP) affects 2.1-24% of women, causing physical and psychological damage to women around the world. Objectives: Based on the efficacy of gabapentin in the treatment of chronic pain, we conducted this study to evaluate the efficacy and safety of gabapentin in reducing pain in female with CPP. Search strategy: Systematic searches were performed in the electronic databases of PubMed, Embase, Web of science, Scopus, Cochrane and Clinicalkey databases. Selection criteria: Studies focused on comparing the efficacy of gabapentin and placebo in the treatment of female CPP patients were included. Data collection and analysis: RevMan 5.4 was used to analyze the results and risk of bias. Two investigators independently selected eligible studies and extracted related pain scores and side effects for meta-analysis. Main results: In total, enrolled 4 RCTs totalling 425 patients in the meta-analysis. Among patients receiving gabapentin, the average pain scores in 3 and 6 months were significantly lower than those in the placebo group(P<0.00001). The results showed that there was no statistical difference between gabapentin and placebo in the reduction of pain scores from baseline(P=0.41). The incidence of side effects in the gabapentin group was significantly higher than that in the placebo group(P<0.00001). Conclusion: This systematic review and meta-analysis demonstrated that for female with CPP, gabapentin was significantly different from placebo in average pain scores at 3 and 6 months. Gabapentin can bring more significant side effects, whether it is a common side effect or a serious side effect. Funding: None.

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (32)

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK